Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neuralgia 1Neoplasms 1Neoplasm Metastasis 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lung Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

Vitamin B 6 1Vitamin B 12 1Vinorelbine 1Vincristine 1Pregabalin 1Paclitaxel 1Oxaliplatin 1Geritol 1Gabapentin 1Drug Therapy 1Docetaxel 1Cisplatin 1Bupivacaine 1Amitriptyline 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neuralgia × Vitamin B 12 × Clear all
NCT00659269 2016-02-26

A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

New Mexico Cancer Research Alliance

Phase 3 Completed
319 enrolled 7 charts

Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡